HNB
UTHR icon

Huntington National Bank’s United Therapeutics UTHR Stock Holding History

Huntington National Bank’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26M Buy
4,164
+74
+2% +$41.7K 0.01% 394
2026
Q1 		$2.43M Buy
4,090
+4,041
+8,247% +$2.01M 0.01% 366
2025
Q4 		$23.9K Sell
49
-5
-9% -$2.33K ﹤0.01% 1516
2025
Q3 		$22.6K Sell
54
-16
-23% -$5.38K ﹤0.01% 1561
2025
Q2 		$20.1K Buy
70
+55
+367% +$16.4K ﹤0.01% 1570
2025
Q1 		$4.62K Sell
15
-18
-55% -$6.17K ﹤0.01% 2004
2024
Q4 		$11.6K Buy
33
+11
+50% +$4.04K ﹤0.01% 1728
2024
Q3 		$7.88K Buy
22
+4
+22% +$1.35K ﹤0.01% 1843
2024
Q2 		$5.74K Buy
18
+6
+50% +$1.59K ﹤0.01% 1884
2024
Q1 		$2.76K Sell
12
-43
-78% -$9.7K ﹤0.01% 2065
2023
Q4 		$12.1K Buy
55
+1
+2% +$230 ﹤0.01% 1593
2023
Q3 		$12.2K Sell
54
-1
-2% -$230 ﹤0.01% 1507
2023
Q2 		$12.1K Buy
55
+19
+53% +$4.21K ﹤0.01% 1513
2023
Q1 		$8.06K Sell
36
-52
-59% -$12.8K ﹤0.01% 1597
2022
Q4 		$24.5K Sell
88
-4
-4% -$1.01K ﹤0.01% 1218
2022
Q3 		$19K Buy
92
+64
+229% +$14.3K ﹤0.01% 1314
2022
Q2 		$7K Sell
28
-2
-7% -$407 ﹤0.01% 1664
2022
Q1 		$5K Buy
30
+1
+3% +$191 ﹤0.01% 1770
2021
Q4 		$6K Buy
+29
New +$5.69K ﹤0.01% 1704
2019
Q3 		– Sell
-589
Closed -$46K – 1777
2019
Q2 		$46K Hold
589
– – ﹤0.01% 879
2019
Q1 		$69K Hold
589
– – ﹤0.01% 783
2018
Q4 		$64K Hold
589
– – ﹤0.01% 775
2018
Q3 		$75K Sell
589
-23
-4% -$2.85K ﹤0.01% 810
2018
Q2 		$69K Sell
612
-8
-1% -$879 ﹤0.01% 847
2018
Q1 		$70K Sell
620
-20
-3% -$2.54K ﹤0.01% 865
2017
Q4 		$95K Hold
640
– – ﹤0.01% 792
2017
Q3 		$75K Sell
640
-72
-10% -$9.2K ﹤0.01% 861
2017
Q2 		$92K Hold
712
– – ﹤0.01% 779
2017
Q1 		$96K Hold
712
– – ﹤0.01% 753
2016
Q4 		$102K Hold
712
– – ﹤0.01% 726
2016
Q3 		$84K Sell
712
-162
-19% -$19.5K ﹤0.01% 817
2016
Q2 		$93K Buy
874
+65
+8% +$7.25K ﹤0.01% 761
2016
Q1 		$140K Buy
809
+37
+5% +$4.68K ﹤0.01% 791
2015
Q4 		$121K Sell
772
-39
-5% -$5.68K ﹤0.01% 751
2015
Q3 		$106K Buy
811
+13
+2% +$2.08K ﹤0.01% 837
2015
Q2 		$139K Sell
798
-11
-1% -$1.98K ﹤0.01% 807
2015
Q1 		$140K Sell
809
-507
-39% -$77.3K ﹤0.01% 800
2014
Q4 		$170K Sell
1,316
-638
-33% -$82.2K ﹤0.01% 730
2014
Q3 		$251K Buy
+1,954
New +$201K 0.01% 875
2014
Q1 		– Sell
-289
Closed -$33K – 1531
2013
Q4 		$33K Sell
289
-2,210
-88% -$199K ﹤0.01% 1215
2013
Q3 		$197K Buy
2,499
+619
+33% +$45.2K 0.01% 668
2013
Q2 		$124K Buy
+1,880
New +$121K ﹤0.01% 784

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Huntington National Bank's UTHR Position: Q2 2026 in Review

Huntington National Bank increased its United Therapeutics (UTHR) stake by 1.8% in Q2 2026, buying an estimated $41.7K and bringing the position to 4,164 shares worth $2.26M. The position accounts for 0.01% of the portfolio, ranked #394.

Huntington National Bank first reported a position in UTHR in Q2 2013 and has held it in 42 quarters since. The position peaked at $2.43M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Huntington National Bank held 4,164 shares of United Therapeutics worth $2.26M as of Q2 2026.
  • Huntington National Bank bought 74 United Therapeutics shares in Q2 2026, an estimated $41.7K.
  • United Therapeutics made up 0.01% of Huntington National Bank's portfolio in Q2 2026, its #394 holding.
  • Huntington National Bank first reported a position in United Therapeutics in Q2 2013 and has held it in 42 quarters since.
  • Huntington National Bank's United Therapeutics position peaked at $2.43M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.